CDXC

ChromaDex Corporation

1.57 USD
+0.05 (+3.29%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ChromaDex Corporation stock is up 2.61% since 30 days ago. The next earnings date is Mar 6, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 7 February’s closed higher than January.

About ChromaDex Corporation

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. It researches on nicotinamide adenine dinucleotide (NAD+) and develops and commercializes proprietary-based ingredient technologies. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform.